(Q33157255)

23 July 2017

title

Risk factors for mortality from primary cryptococcosis in patients with HIV. (English)

1 reference

23 July 2017

1 reference

1

Mohammad M Sajadi

1 reference

23 July 2017

Kristina M Roddy

2

1 reference

23 July 2017

Kirk M Chan-Tack

series ordinal

3

1 reference

23 July 2017

Graeme N Forrest

series ordinal

4

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

23 July 2017

published in

Postgraduate Medicine

1 reference

23 July 2017

volume

121

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

107-113

1 reference

Prognostic factors in cryptococcal meningitis. A study in 111 cases

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

HIV-associated cryptococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Epidemiology and management of cryptococcal meningitis: developments and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Treatment of cryptococcosis in the setting of HIV coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Editorial commentary: dosing amphotericin B in cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immunorestitution disease involving the innate and adaptive response

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Clinical indicators of immune restoration following highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immune reconstitution inflammatory syndrome in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Immune reconstitution inflammatory syndrome: more answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.03.1983

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.03.1983

1 reference

23 July 2017

1 reference